| 000 | 01063 a2200289 4500 | ||
|---|---|---|---|
| 005 | 20250513202020.0 | ||
| 264 | 0 | _c20000217 | |
| 008 | 200002s 0 0 eng d | ||
| 022 | _a0012-6667 | ||
| 024 | 7 |
_a10.2165/00003495-199958060-00008 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLamb, H M | |
| 245 | 0 | 0 |
_aQuinupristin/dalfopristin: a review of its use in the management of serious gram-positive infections. _h[electronic resource] |
| 260 |
_bDrugs _cDec 1999 |
||
| 300 |
_a1061-97 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aAnti-Bacterial Agents _xadverse effects |
| 650 | 0 | 4 | _aDrug Resistance, Microbial |
| 650 | 0 | 4 |
_aGram-Positive Bacteria _xdrug effects |
| 650 | 0 | 4 |
_aGram-Positive Bacterial Infections _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aVirginiamycin _xadverse effects |
| 700 | 1 | _aFiggitt, D P | |
| 700 | 1 | _aFaulds, D | |
| 773 | 0 |
_tDrugs _gvol. 58 _gno. 6 _gp. 1061-97 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.2165/00003495-199958060-00008 _zAvailable from publisher's website |
| 999 |
_c10606430 _d10606430 |
||